Search research articles
Contact Us
Filters
Showing results (91-100 of 159) with videos related to
Page
of 16
Sort By:
European Journal of Nuclear Medicine
|
July 15, 1998
The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours
B Stolz, G Weckbecker, P M Smith-Jones, et al.
Obesity Surgery
|
August 26, 2016
Does Certification as Bariatric Surgery Center and Volume Influence the Outcome in RYGB-Data Analysis of German Bariatric Surgery Registry
Christine Stroh, F Köckerling, V Lange, et al.
Gastroenterology
|
June 1, 1991
Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization
G Fricker, C Bruns, J Munzer, et al.
Life Sciences
|
January 1, 1993
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
R Albert, P Marbach, W Bauer, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man
R Albert, P Smith-Jones, B Stolz, et al.
Domestic Animal Endocrinology
|
February 21, 2019
Responsiveness of swine divergently selected for feed efficiency to exogenous adrenocorticotropic hormone and glucose challenges
J Colpoys, D Van Sambeek, C Bruns, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Sandostatin LAR in acromegalic patients: long-term treatment
A K Fløgstad, J Halse, S Bakke, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1995
Sandostatin LAR in acromegalic patients: a dose-range study
A K Fløgstad, J Halse, T Haldorsen, et al.
Transplantation Proceedings
|
September 18, 1997
The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection
G Weckbecker, C Pally, F Raulf, et al.
Hormone and Metabolic Research. Supplement Series
|
January 1, 1993
New octreotide derivatives for in vivo targeting of somatostatin receptor-positive tumors for single photon emission computed tomography (SPECT) and positron emission tomography (PET)
H R Mäcke, P Smith-Jones, T Maina, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 159) with videos related to
Sort By:
Page
of 16
European Journal of Nuclear Medicine
|
July 15, 1998
The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours
B Stolz, G Weckbecker, P M Smith-Jones, et al.
Obesity Surgery
|
August 26, 2016
Does Certification as Bariatric Surgery Center and Volume Influence the Outcome in RYGB-Data Analysis of German Bariatric Surgery Registry
Christine Stroh, F Köckerling, V Lange, et al.
Gastroenterology
|
June 1, 1991
Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization
G Fricker, C Bruns, J Munzer, et al.
Life Sciences
|
January 1, 1993
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
R Albert, P Marbach, W Bauer, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man
R Albert, P Smith-Jones, B Stolz, et al.
Domestic Animal Endocrinology
|
February 21, 2019
Responsiveness of swine divergently selected for feed efficiency to exogenous adrenocorticotropic hormone and glucose challenges
J Colpoys, D Van Sambeek, C Bruns, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Sandostatin LAR in acromegalic patients: long-term treatment
A K Fløgstad, J Halse, S Bakke, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 1, 1995
Sandostatin LAR in acromegalic patients: a dose-range study
A K Fløgstad, J Halse, T Haldorsen, et al.
Transplantation Proceedings
|
September 18, 1997
The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection
G Weckbecker, C Pally, F Raulf, et al.
Hormone and Metabolic Research. Supplement Series
|
January 1, 1993
New octreotide derivatives for in vivo targeting of somatostatin receptor-positive tumors for single photon emission computed tomography (SPECT) and positron emission tomography (PET)
H R Mäcke, P Smith-Jones, T Maina, et al.
Page
of 16